Introduction
============

The Cancer Reform Strategy \[[@B1]\] and NICE guidelines \[[@B2]\] highlighted the need to identify women at increased genetic risk of breast cancer. Following this, a magnetic resonance imaging (MRI) screening service was established in Newcastle.

Methods
=======

Women were identified from the Regional Genetic Centre database, following assessment by a consultant geneticist as high risk according to the NICE guidelines \[[@B2]\]. Screening comprised annual MRI ± mammography, depending on their age, following the standards set by the NHSBSP \[[@B3]\]. All investigations were double-read by NHSBSP-compliant radiologists.

Results
=======

A total of 142 women underwent 311 screening episodes between January 2008 and June 2012. There were 28 recalls (9%) for second-look ultrasound in 24 women. Thirteen lesions had a core biopsy, from which six (1.9%) malignancies were identified of varying histological type, size and grade. Seven lesions were benign. No ultrasound abnormality was found in the remaining 15 lesions. No interval cancers have developed.

Conclusion
==========

In our unit, high-risk MRI screening is effective and efficient, with a cancer detection rate of 0.2 per 1,000 women screened and no false negative screens to date, with an acceptable recall rate for second-look ultrasound (within the standard set under the NHSBSP guidelines). This has been possible due to the close liaison between the departments of Genetics and Breast Screening.
